SUBA™-Itraconazole to be Tested in Combination with Standard of Care Chemotherapy for Metastatic Castrate Resistant Prostate Cancer
FDA Confirms the Proposed Phase 2b Study Adequately Addresses the Objectives Necessary to Support a Regulatory Submission
PR Newswire
TAMPA, Fla., Jan. 22, 2020